Which Trial Do We Need? Plasma Metagenomic Next-Generation Sequencing to Diagnose Infections in Patients with Hematological Malignancies and Febrile Neutropenia: Proposal for A Randomized-controlled Trial.

[1]  David C. Gaston.  Clinical Metagenomics for Infectious Diseases: Progress toward Operational Value , 2023, Journal of clinical microbiology.

[2]  R. Sabo,et al.  Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study , 2023, Transplant infectious disease : an official journal of the Transplantation Society.

[3]  P. Neumeister,et al.  Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies , 2022, Open forum infectious diseases.

[4]  S. Cruveiller,et al.  Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia , 2022, PloS one.

[5]  P. Luethy,et al.  Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study , 2022, BMC Infectious Diseases.

[6]  P. Revell,et al.  Clinical Impact of Plasma Metagenomic Next-generation Sequencing in a Large Pediatric Cohort , 2021, The Pediatric infectious disease journal.

[7]  A. Tremoulet,et al.  Clinical application of cell-free next-generation sequencing for infectious diseases at a tertiary children’s hospital , 2021, BMC Infectious Diseases.

[8]  T. Blauwkamp,et al.  Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Taplitz,et al.  Updates in infection risk and management in acute leukemia. , 2020, Hematology. American Society of Hematology. Education Program.

[10]  T. Blauwkamp,et al.  Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Revell,et al.  Plasma Metagenomic Next-Generation Sequencing Assay for Identifying Pathogens: a Retrospective Review of Test Utilization in a Large Children's Hospital , 2020, Journal of Clinical Microbiology.

[12]  Rose A. Lee,et al.  Assessment of the Clinical Utility of Plasma Metagenomic Next-Generation Sequencing in a Pediatric Hospital Population , 2020, Journal of Clinical Microbiology.

[13]  J. Derisi,et al.  Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis , 2020, PLoS ONE.

[14]  B. Pinsky,et al.  Clinical Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA for the Diagnosis of Infectious Diseases: A Multicenter Retrospective Cohort Study. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Soyang Kwon,et al.  Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center Experience , 2019, Open forum infectious diseases.

[16]  Y. Vainshtein,et al.  Enhanced Performance of Next-Generation Sequencing Diagnostics Compared With Standard of Care Microbiological Diagnostics in Patients Suffering From Septic Shock , 2019, Critical care medicine.

[17]  T. Blauwkamp,et al.  Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease , 2019, Nature Microbiology.

[18]  J. Locascio,et al.  Randomised controlled trials – the gold standard for effectiveness research , 2018, BJOG : an international journal of obstetrics and gynaecology.

[19]  Karen C Carroll,et al.  Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Joseph L DeRisi,et al.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.